Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice

Andersen, 2017, Alterations in cerebral cortical glucose and glutamine metabolism precedes amyloid plaques in the APPswe/PSEN1dE9 mouse model of Alzheimer’s disease, Neurochem Res., 42, 1589, 10.1007/s11064-016-2070-2 Anderson, 2000, Astrocyte glutamate transport: Review of properties, regulation, and physiological functions, Glia., 32, 1, 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W Baek, 2019, Glutamine supplementation ameliorates chronic stress-induced reductions in glutamate and glutamine transporters in the mouse prefrontal cortex, Exp Neurobiol., 28, 270, 10.5607/en.2019.28.2.270 Bak, 2006, The glutamate/GABA-glutamine cycle: Aspects of transport, neurotransmitter homeostasis and ammonia transfer, J Neurochem., 98, 641, 10.1111/j.1471-4159.2006.03913.x Billups, 2013, Inducible presynaptic glutamine transport supports glutamatergic transmission at the calyx of Held synapse, J Neurosci., 33, 17429, 10.1523/JNEUROSCI.1466-13.2013 Buntup, 2008, β-amyloid 25–35 peptide reduces the expression of glutamine transporter SAT1 in cultured cortical neurons, Neurochem Res., 33, 248, 10.1007/s11064-007-9527-2 Burbaeva, 2014, Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer’s disease: Phosphate-activated glutaminase and glutamic acid decarboxylase, Cerebellum., 13, 607, 10.1007/s12311-014-0573-4 Burbaeva, 2013, Glutaminase in the cerebellum of patients with Alzheimer’s disease: A postmortem brain study, Zh Nevrol Psikhiatr Im S S Korsakova., 113, 71 Canas, 2014, Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer’s disease, Neuropharmacology., 76, 51, 10.1016/j.neuropharm.2013.08.026 Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, LaFerla FM, Nicoletti F, Cuomo V, Vendemiale G. Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging. 2012, 33(6): 1121.e1-12. Danbolt, 2001, Glutamate uptake, Prog Neurobiol., 65, 1, 10.1016/S0301-0082(00)00067-8 Fan, 2018, Ceftriaxone improves cognitive function and upregulates GLT-1-related glutamate-glutamine cycle in APP/PS1 mice, J Alzheimers Dis., 66, 1731, 10.3233/JAD-180708 He, 2012, Neurodevelopmental role for VGLUT2 in pyramidal neuron plasticity, dendritic refinement, and in spatial learning, J Neurosci., 32, 15886, 10.1523/JNEUROSCI.4505-11.2012 Hoxha, 2012, Excitability and synaptic alterations in the cerebellum of APP/PS1 mice, PLoS One., 7, 10.1371/journal.pone.0034726 Iyer, 2016, N-Glycosylation influences transport, but not cellular trafficking, of a neuronal amino acid transporter SNAT1, Biochem J., 473, 4227, 10.1042/BCJ20160724 Jones, 2019, Aberrant iPSC-derived human astrocytes in Alzheimer’s disease, Cell Death Dis., 10, 244, 10.1038/s41419-019-1422-7 Kim, 2011, Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics, J Cell Physiol., 226, 2484, 10.1002/jcp.22609 Kirvell, 2010, Vesicular glutamate transporter and cognition in stroke: A case-control autopsy study, Neurology., 75, 1803, 10.1212/WNL.0b013e3181fd6328 Köfalvi, 2005, Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: A combined immunochemical and pharmacological analysis, J Neurosci., 25, 2874, 10.1523/JNEUROSCI.4232-04.2005 Krzyzanowska, 2016, N-acetylcysteine and ceftriaxone as preconditioning strategies in focal brain ischemia: Influence on glutamate transporters expression, Neurotox Res., 29, 539, 10.1007/s12640-016-9602-z Kulijewicz-Nawrot, 2013, Astrocytes and glutamate homoeostasis in Alzheimer’s disease: A decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex, ASN Neuro., 5, 273, 10.1042/AN20130017 Liguz-Lecznar, 2007, Vesicular glutamate transporters (VGLUTs): The three musketeers of glutamatergic system, Acta Neurobiol Exp., 67, 207 Liu, 2012, The role of glutamate transporter-1a in the induction of brain ischemic tolerance in rats, Glia., 60, 112, 10.1002/glia.21252 Mariko Kato Hayashi, 2018, Structure-function relationship of transporters in the glutamate–glutamine cycle of the central nervous system, Int. J. Mol. Sci., 19, 1177, 10.3390/ijms19041177 Masson, 2006, Mice lacking brain/kidney phosphate-activated glutaminase have impaired synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth, J Neurosci., 26, 4660, 10.1523/JNEUROSCI.4241-05.2006 Mimura, 2011, Ceftriaxone preconditioning confers neuroprotection in neonatal rats through glutamate transporter 1 upregulation, Reprod Sci., 18, 1193, 10.1177/1933719111410710 Mitew, 2013, Altered synapses and gliotransmission in Alzheimer’s disease and AD model mice, Neurobiol Aging., 34, 2341, 10.1016/j.neurobiolaging.2013.04.010 Mookherjee, 2011, GLT-1 loss accelerates cognitive deficit onset in an Alzheimer’s disease animal model, J Alzheimers Dis., 26, 447, 10.3233/JAD-2011-110503 Nilsen, 2014, Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer’s disease, J Cereb Blood Flow Metab., 34, 906, 10.1038/jcbfm.2014.37 Overstreet-Wadiche, 2014, Good housekeeping, Neuron., 81, 715, 10.1016/j.neuron.2014.02.004 Poirel, 2018, Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages, Sci Rep., 8, 938, 10.1038/s41598-018-19154-y Robinson, 2014, Perforant path synaptic loss correlates with cognitive impairment and Alzheimer’s disease in the oldest-old, Brain., 137, 2578, 10.1093/brain/awu190 Rodriguez-Perdigon, 2016, Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer’s disease, Hippocampus., 26, 1303, 10.1002/hipo.22607 Rothstein, 2005, Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression, Nature., 433, 73, 10.1038/nature03180 Ruzicka, 2016, Mesenchymal stem cells preserve working memory in the 3xTg-AD mouse model of Alzheimer’s disease, Int J Mol Sci., 17, 390, 10.3390/ijms17020152 Schallier, 2011, Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer’s disease, J Alzheimers Dis., 24, 287, 10.3233/JAD-2011-101005 Shen, 2014, Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse, J Neurosci., 34, 5649, 10.1523/JNEUROSCI.4564-13.2014 Sokolow, 2012, Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer’s disease cortex, Neurobiol Dis., 45, 381, 10.1016/j.nbd.2011.08.027 Sosunov, 2013, Phenotypic conversions of “protoplasmic” to “reactive” astrocytes in Alexander disease, J Neurosci., 33, 7439, 10.1523/JNEUROSCI.4506-12.2013 Tani, 2014, A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release, Neuron., 81, 888, 10.1016/j.neuron.2013.12.026 Tani, 2010, Glutamine is required for persistent epileptiform activity in the disinhibited neocortical brain slice, J Neurosci., 30, 1288, 10.1523/JNEUROSCI.0106-09.2010 Zhang, 2007, The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats, J Cereb Blood Flow Metab., 27, 1352, 10.1038/sj.jcbfm.9600441 Zhou, 2018, Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: A 13C NMR metabolomic study, Metab Brain Dis., 33, 1661, 10.1007/s11011-018-0274-7